Satellos Bioscience Inc T.MSCL

Alternate Symbol(s): MSCLF

Healthcare Biotechnology

Satellos Bioscience Inc. is a Canada-based a drug discovery and development company with a focus on muscle regeneration. The Company is focused on developing medicines to treat degenerative muscle conditions. Its MyoReGenX platform is specifically designed to recreate the specialized muscle stem cell niche in vitro. MyoReGenX platform enables to map pathways which modulate muscle repair and regeneration, identify, and confirm drug targets, and test drug candidates for their ability to restore muscle stem cell repair mechanisms that have been impaired by genetic mutations, disease or injury. Its lead program is an oral, small molecule drug candidate in development as a disease-modifying treatment for Duchenne muscular dystrophy. Its iCo portfolio includes Oral Amp B Delivery System, a patented oral transport technology and Bertilimumab a human monoclonal eotaxin antibody with potential to treat a range of allergic and inflammatory conditions mediated by eotaxin-1.

TSX:MSCL - Post by User

Satellos Bioscience Inc > Very nice stock

<< Previous

Bullboard Posts

Next >>

Comment by Smiles62on Aug 27, 2021 4:04pm

129 Views

Post# 33777001

RE:RE:RE:Very nice stock

Smiles62 wrote:

Smiles62 wrote: Got in at 1.54, sold at 1.59. Now have a bid at 1.53. I will adjust according to bids and asks at 9:28

Before this trade my average cost was 2.20 (0.11), now it's at 1.95. Hopefully I will be lucky enough to bring it down to 1.80 in the next 2 weeks. That would represent 0.09 instead of 0.11 before the reverse.

Back in at 1.53 and 1.58, my average is now 1.81.

<< Previous

Bullboard Posts

Next >>

Northstar Gold surveys large potential copper resource extension